<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vinall, Maria</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Holtzman, David M.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">A Review of the Current Understanding and Treatment of Alzheimer's Disease</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2014-06-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">4-6</style></pages><abstract><style  face="normal" font="default" size="100%">The Robert Wartenberg Lecture is the premier award and address at the American Academy of Neurology's Annual Meeting. In 2014, the award was given to David M. Holtzman, MD, Washington University School of Medicine, St. Louis, Missouri, USA. Dr. Holtzman lectured on the current state of our understanding of biomarkers for Alzheimer's disease (AD) and potential immunotherapeutic approaches.</style></abstract><number><style face="normal" font="default" size="100%">6</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>